Is percutaneous endoscopic gastrostomy tube placement safe in patients with ventriculoperitoneal shunts?  

作　　者：Jin-Soo Kim Yong-Wan Park Hyung-Keun Kim Young-Seok Cho Sung-Soo Kim Na-Ri Youn Hiun-Suk Chae 

机构地区：[1]Division of Gastroenterology,Department of Internal Medicine,College of Medicine,The Catholic University of Korea,Uijeongbu St. Mary's Hospital

出　　处：《World Journal of Gastroenterology》2009年第25期3148-3152,共5页世界胃肠病学杂志（英文版）

摘　　要：AIM:To investigate whether percutaneous endoscopic gastrostomy (PEG) tube placement is safe in patients with ventriculoperitoneal (VP) shunts.METHODS: This was a retrospective study of all patients undergoing PEG insertion at our institution between June 1999 and June 2006. Post-PEG complications were compared between two groups according to the presence or absence of VP shunts. VP shunt infection rates, the interval between PEG placement and VP shunt catheter insertion, and long-term follow-up were also investigated.RESULTS: Fifty-five patients qualified for the study. Seven patients (12.7%) had pre-existing VP shunts. All patients received prophylactic antibiotics. The complication rate did not differ between VP shunt patients undergoing PEG (PEG/VP group) and non-VP shunt patients undergoing PEG (control group) [1 (14.3%) vs 6 (12.5%), P=1.000]. All patients in the PEG/VP group had undergone VP shunt insertion prior to PEG placement. The mean interval between VP shunt insertion and PEG placement was 308.7 d (range, 65-831 d). The mean follow-up duration in the PEG/VP group was 6.4 mo (range, 1-15 mo). There were no VP shunt infections, although one patient in the PEG/VP group developed a minor peristomal infection during follow-up.CONCLUSION: Complications following PEG placement in patients with VP shunts were infrequent in this study.AIM： To investigate whether percutaneous endoscopic gastrostomy （PEG） tube placement is safe in patients with ventriculoperitoneal （VP） shunts. METHODS： This was a retrospective study of all patients undergoing PEG insertion at our institution between June 1999 and June 2006. Post-PEG complications were compared between two groups according to the presence or absence of VP shunts. VP shunt infection rates, the interval between PEG placement and VP shunt catheter insertion, and long- term follow-up were also investigated. RESULTS： Fifty-five patients qualified for the study. Seven patients （12.7%） had pre-existing VP shunts. All patients received prophylactic antibiotics. The complication rate did not differ between VP shunt patients undergoing PEG （PEG/VP group） and non-VP shunt patients undergoing PEG （control group） [1 （14.3%） vs 6 （12.5%）, P = 1.000]. All patients in the PEG/VP group had undergone VP shunt insertion prior to PEG placement. The mean interval between VP shunt insertion and PEG placement was 308.7 d （range, 65-831 d）. The mean follow-up duration in the PEG/VP group was 6.4 mo （range, 1-15 mo）. There were no VP shunt infections, although one patient in the PEG/VP group developed a minor peristomal infection during follow-up. CONCLUSION： Complications following PEG placement in patients with VP shunts were infrequent in this study.

关 键 词：Percutaneous endoscopic gastrostomy Ventriculoperitoneal shunt COMPLICATION Ventriculo- peritoneal shunt infection Prophylactic antibiotic 

分 类 号：R651.1[医药卫生—外科学] R656.6[医药卫生—临床医学]